BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15024178)

  • 1. Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection.
    Gamberg J; Barrett L; Bowmer I; Howley C; Grant M
    J Clin Immunol; 2004 Mar; 24(2):115-24. PubMed ID: 15024178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
    Palmer BE; Boritz E; Blyveis N; Wilson CC
    J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Preexisting Immunological Memory Among Human Immunodeficiency Virus-Infected Women Despite Immune Reconstitution With Antiretroviral Therapy.
    Thomas A; Hammarlund E; Gao L; Holman S; Michel KG; Glesby M; Villacres MC; Golub ET; Roan NR; French AL; Augenbraun MH; Slifka MK
    J Infect Dis; 2020 Jun; 222(2):243-251. PubMed ID: 31867597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
    Sáez-Cirión A; Lacabaratz C; Lambotte O; Versmisse P; Urrutia A; Boufassa F; Barré-Sinoussi F; Delfraissy JF; Sinet M; Pancino G; Venet A;
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6776-81. PubMed ID: 17428922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.
    Streeck H; Jolin JS; Qi Y; Yassine-Diab B; Johnson RC; Kwon DS; Addo MM; Brumme C; Routy JP; Little S; Jessen HK; Kelleher AD; Hecht FM; Sekaly RP; Rosenberg ES; Walker BD; Carrington M; Altfeld M
    J Virol; 2009 Aug; 83(15):7641-8. PubMed ID: 19458000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.
    Rehr M; Cahenzli J; Haas A; Price DA; Gostick E; Huber M; Karrer U; Oxenius A
    J Virol; 2008 Apr; 82(7):3391-404. PubMed ID: 18199637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.
    Stebbing J; Bower M; Mandalia S; Nelson M; Gazzard B
    Clin Exp Immunol; 2006 Aug; 145(2):271-6. PubMed ID: 16879246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy.
    Stevenson EM; Ward AR; Truong R; Thomas AS; Huang SH; Dilling TR; Terry S; Bui JK; Mota TM; Danesh A; Lee GQ; Gramatica A; Khadka P; Alberto WDC; Gandhi RT; McMahon DK; Lalama CM; Bosch RJ; Macatangay B; Cyktor JC; Eron JJ; Mellors JW; Jones RB;
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors.
    Papagno L; Appay V; Sutton J; Rostron T; Gillespie GM; Ogg GS; King A; Makadzanhge AT; Waters A; Balotta C; Vyakarnam A; Easterbrook PJ; Rowland-Jones SL
    Clin Exp Immunol; 2002 Dec; 130(3):509-17. PubMed ID: 12452843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.
    Pallikkuth S; Wanchu A; Bhatnagar A; Sachdeva RK; Sharma M
    Clin Vaccine Immunol; 2007 Sep; 14(9):1196-202. PubMed ID: 17823271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Álvarez-Ríos AI; Genebat M; Abad-Carrillo MA; Ruiz-Mateos E; Pulido F; González-García J; Montero M; Bernal-Morell E; Vidal F; Leal M; Pacheco YM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
    Oxenius A; McLean AR; Fischer M; Price DA; Dawson SJ; Hafner R; Schneider C; Joller H; Hirschel B; Phillips RE; Weber R; Günthard HF;
    J Virol; 2002 Oct; 76(20):10169-76. PubMed ID: 12239291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza.
    Nabeshima S; Murata M; Kikuchi K; Ikematsu H; Kashiwagi S; Hayashi J
    Clin Exp Immunol; 2002 May; 128(2):339-46. PubMed ID: 11985525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.
    Herasimtschuk AA; Westrop SJ; Moyle GJ; Downey JS; Imami N
    J Immune Based Ther Vaccines; 2008 Oct; 6():7. PubMed ID: 18976455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.
    Garcia-Beltran WF; Claiborne DT; Maldini CR; Phelps M; Vrbanac V; Karpel ME; Krupp KL; Power KA; Boutwell CL; Balazs AB; Tager AM; Altfeld M; Allen TM
    Front Immunol; 2021; 12():667393. PubMed ID: 34122425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.
    Hersperger AR; Migueles SA; Betts MR; Connors M
    Curr Opin HIV AIDS; 2011 May; 6(3):169-73. PubMed ID: 21399496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Huang SH; McCann CD; Mota TM; Wang C; Lipkin SM; Jones RB
    Front Immunol; 2019; 10():1842. PubMed ID: 31447850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prediction model to evaluate the probability of CD4+/CD8+ cell ratio restoration in HIV-infected individuals.
    Li B; Zhang L; Liu Y; Xiao J; Li C; Fan L; Duan Y; Xiao J; Hao Y; Han J; Kong Y; Zhao H
    AIDS; 2022 May; 36(6):795-804. PubMed ID: 35013083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.
    Rodriguez B; Valdez H; Lange CG; Asaad R; Medvik K; Sieg SF
    Clin Immunol; 2010 Sep; 136(3):400-8. PubMed ID: 20472504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of cytotoxic and helper T cell responses.
    Schepers K; Arens R; Schumacher TN
    Cell Mol Life Sci; 2005 Dec; 62(23):2695-710. PubMed ID: 16231088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.